How big is the Saudi Arabia Diabetes Drugs Market?

The Saudi Arabia Diabetes Drugs Market size is expected to reach USD 1.87 billion in 2024 and grow at a CAGR of 9% to reach USD 2.89 billion by 2029. Read More

What is the current Saudi Arabia Diabetes Drugs Market size?

In 2024, the Saudi Arabia Diabetes Drugs Market size is expected to reach USD 1.87 billion. Read More

Who are the key players in Saudi Arabia Diabetes Drugs Market?

AstraZeneca, Boehringer Ingelheim, Merck and Co., Novo Nordisk A/S and Sanofi Aventis are the major companies operating in the Saudi Arabia Diabetes Drugs Market. Read More

What years does this Saudi Arabia Diabetes Drugs Market cover, and what was the market size in 2023?

In 2023, the Saudi Arabia Diabetes Drugs Market size was estimated at USD 1.70 billion. The report covers the Saudi Arabia Diabetes Drugs Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Saudi Arabia Diabetes Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Saudi Arabia Diabetes Drugs Market Share

Statistics for the 2023 & 2024 Saudi Arabia Diabetes Drugs market share, created by Mordor Intelligence™ Industry Reports. Saudi Arabia Diabetes Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Saudi Arabia Diabetes Drugs Industry

The Saudi Arabia Diabetes Drugs Market is consolidated, with major manufacturers, namely Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca, and other generic players, holding a presence in the region. A major share of the market is held by manufacturers concomitant with strategy-based M&A operations and constantly entering the market to generate new revenue streams and boost existing ones.